Goodman Group saw the highest growth of 99% in patent filings in October and 199% in grants in December in Q4 2023. Compared to Q3 2023, Q4 2023 saw an increase in patent filings by 99% and no change in grants. GlobalData’s DataBook provides a comprehensive analysis of Goodman Group’s patent filings and grants. Buy the databook here.
Goodman Group has been focused on protecting inventions in Australia(AU) with one publication in Q4 2023
The Australia(AU) Patent Office dominates the patent filings and grants with nearly 50% filings and 0% grants. The Australia(AU), China(CN), European Patent Office(EPO), and Spain(ES) patent Office are among the top ten patent offices where Goodman Group is filings its patents. Among the top granted patent authorities, Goodman Group has 33% of its grants in European Patent Office(EPO), 33% in Spain(ES) and 33% in United States(US).
Johnson & Johnson could be the strongest competitor for Goodman Group
See Also:
Cardiovascular devices related patents lead Goodman Group portfolio
Goodman Group has highest number of patents in cardiovascular devices.
For comprehensive analysis of Goodman Group's filings and grants, buy the databook here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.